Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab
Conditions:   NSCLC;   Esophageal Cancer;   Gastric Cancer;   Head and Neck Squamous Cell Carcinoma;   Urothelial Carcinoma
Interventions:   Drug: IMC-C103C;   Drug: Atezolizumab
Sponsor:   Immunocore Ltd
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 18, 2019 / by / in
Comments